Department of Medical Oncology (Liver Tumors)
Zhongshan Hospital, Fudan University, Shanghai
肝肿瘤内科 · Medical Oncology
Established in 1969, this department specializes in the non-surgical and comprehensive treatment of liver tumors. It manages primary and secondary liver cancer, as well as benign liver conditions such as cysts, hemangiomas, and abscesses. The team offers interventional therapies including hepatic artery chemoembolization and various ablation techniques (radiofrequency, microwave, laser). Additional treatments include molecular targeted therapy with sorafenib, biological therapies like CIK cells, and intralesional alcohol injection. The department performs over 4,000 chemoembolization procedures and 1,500 local ablations annually. It also provides diagnostic biopsies, drainage for cysts or abscesses, and biliary drainage for obstructive jaundice.
What the department treats
- Treatment of primary and secondary liver cancer
- Hepatic artery chemoembolization (TACE)
- Radiofrequency, microwave, and laser ablation
- Molecular targeted therapy (sorafenib) and biological therapy
- Management of benign liver lesions (cysts, hemangiomas, abscesses)
- Diagnostic biopsy and biliary drainage (PTCD)
Key facts
- The department was founded in 1969 as a liver cancer diagnosis and treatment group.
- There are 26 doctors on staff, with over 90% holding doctoral degrees.
- The department performs over 4,000 hepatic artery chemoembolization cases and more than 1,500 local ablation cases annually.
As described by the hospital.
Team
32 doctors listed, including 6 chief physicians. Its chief physicians have 51 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Dr. Xin Yin 殷欣 | Diagnosis and treatment of benign and malignant liver tumors, including primary liver cancer, cholangiocarcinoma, and metastatic liver cancer. Specializes in interventional therapy, ablation, targeted therapy, immunotherapy, and ultrasound-guided interventions for benign liver tumors. | 22 |
| Dr. Rongxin Chen 陈荣新 | Diagnosis and treatment of liver diseases, with a focus on liver tumors. Expertise includes interventional therapy, minimally invasive therapy, and comprehensive treatment. | 21 |
| Dr. Biwei Yang 杨毕伟 | Diagnosis of liver masses; non-surgical treatment of liver cancer including interventional procedures, ablation, targeted and immunotherapy. Specializes in transradial access interventions and managing refractory or elderly cases. | 7 |
| Dr. Ningling Ge 葛宁灵 | Diagnosis of liver tumors. Local ablation, interventional therapy, biological targeted therapy, and comprehensive treatment for benign and malignant liver tumors. | 1 |
| Dr. Peng Wang 王鹏 · Associate Professor | Minimally invasive tumor ablation, including radiofrequency and microwave ablation for liver and lung tumors, and vascular intervention for pancreatic tumors. | checking |
| Dr. Lan Zhang 张岚 | Minimally invasive ablation, interventional therapy, molecular targeted therapy, and comprehensive treatment for liver tumors. | checking |
Associate chief physicians
- Dr. Tongchun Xue薛同春
- Dr. Yi Chen陈漪
- Dr. Ye Li李烨
- Dr. Yan Wang王妍
- Dr. Zhiying Zhao赵志英
- Dr. Lixin Li李立新
- Dr. Xiaoying Xie谢晓莺
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion